-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Omega Healthcare Invts, Lowers Price Target to $52

Benzinga·10/13/2026 21:21:43
Listen to the news
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and lowers the price target from $54 to $52.